Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced the appointment of Marshall Mohr to its Board of Directors to further ...

Capstan Medical Inc. closed an oversubscribed series C fundraising round that brought in $110 million for the structural heart-focused company. Capstan aims to combine valve implants, advanced ...

"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.

SAN DIEGO--(BUSINESS WIRE)--Capstan Therapeutics, Inc. (“Capstan”), a biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid ...

A startup that aims to integrate robotics with minimally invasive heart valve procedures has collected $31.4 million in venture capital funding. While robots have made inroads in many different types ...